Company description

Gilead Sciences, Inc. (ticker: GILD) is a biopharmaceutical company that focuses on discovering, developing, and commercializing innovative therapies for life-threatening diseases. The company's primary areas of research include antiviral, oncology, and respiratory diseases. Gilead's product portfolio consists of a wide range of treatments for HIV, hepatitis B and C, and cancers such as lymphoma and leukemia. With a mission to improve patient outcomes and advance global health, the company has a strong commitment to innovation and investing in cutting-edge research and development. Gilead has a global presence, with operations in more than 35 countries and a diverse team of over 13,000 employees. Through strategic partnerships and collaborations, the company continues to expand its reach and make a positive impact in the healthcare industry. In summary, Gilead Sciences is a dynamic and pioneering company that leverages its expertise in biopharmaceuticals to bring life-saving treatments to patients around the world.